Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma

DMM Disease Models and Mechanisms

Volumn 8, Issue 5, 2015, Pages 429-441

  Wylie, Luke A ^a,b   Hardwick, Laura J A ^a   Papkovskaia, Tatiana D ^a   Thiele, Carol J ^b   Philpott, Anna ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ascl1; Cell cycle; Development; Differentiation; Neuroblastoma; Xenopus

Indexed keywords

BETA GALACTOSIDASE; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR SLUG; ASCL1 PROTEIN, XENOPUS; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MORPHOLINO OLIGONUCLEOTIDE; NERVE PROTEIN; XENOPUS PROTEIN; XICL PROTEIN, XENOPUS;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MORTALITY; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; GENE MUTATION; GENOME; NERVE CELL DIFFERENTIATION; NEURAL CREST; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYB; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; WILD TYPE; XENOPUS; ADRENERGIC NERVE CELL; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; EMBRYOLOGY; GENE SILENCING; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONMAMMALIAN EMBRYO; PATHOLOGY; PHOSPHORYLATION; XENOPUS LAEVIS;

ANURA; MAMMALIA;

ADRENERGIC NEURONS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOMARKERS; CELL DIFFERENTIATION; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; EMBRYO, NONMAMMALIAN; GENE KNOCKDOWN TECHNIQUES; MORPHOLINOS; NERVE TISSUE PROTEINS; NEURAL CREST; NEUROBLASTOMA; NEUROGENESIS; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 84928983569     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.018630     Document Type: Article

References (53)

1. Ali, F., Hindley, C., McDowell, G., Deibler, R., Jones, A., Kirschner, M., Guillemot, F. and Philpott, A. (2011). Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Development 138, 4267-4277.
2. Ali, F. R., Cheng, K., Kirwan, P., Metcalfe, S., Livesey, F. J., Barker, R. A. and Philpott, A. (2014). The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro. Development 141, 2216-2224.
3. Bellmeyer, A., Krase, J., Lindgren, J. and LaBonne, C. (2003). The protooncogene c-myc is an essential regulator of neural crest formation in xenopus. Dev. Cell 4, 827-839.
4. Berry, T., Luther, W., Bhatnagar, N., Jamin, Y., Poon, E., Sanda, T., Pei, D., Sharma, B., Vetharoy, W. R., Hallsworth, A. et al. (2012). The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell 22, 117-130.
5. Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K.-A., Birchmeier, C. and Wegner, M. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66-78.
6. Brodeur, G. M. (2003). Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3, 203-216.
7. Castro, D. S., Martynoga, B., Parras, C., Ramesh, V., Pacary, E., Johnston, C., Drechsel, D., Lebel-Potter, M., Garcia, L. G., Hunt, C. et al. (2011). A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Genes Dev. 25, 930-945.
8. De Preter, K., Vandesompele, J., Heimann, P., Yigit, N., Beckman, S., Schramm, A., Eggert, A., Stallings, R. L., Benoit, Y., Renard, M. et al. (2006). Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol. 7, R84.
9. Ernsberger, U., Sendtner, M. and Rohrer, H. (1989). Proliferation and differentiation of embryonic chick sympathetic neurons: effects of ciliary neurotrophic factor. Neuron 2, 1275-1284.
10. Guillemot, F., Lo, L.-C., Johnson, J. E., Auerbach, A., Anderson, D. J. and Joyner, A. L. (1993). Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75, 463-476.
11. Hardwick, L. J. A. and Philpott, A. (2014). Nervous decision-making: to divide or differentiate. Trends Genet. 30, 254-261.
12. Honoré, S. M., Aybar, M. J. and Mayor, R. (2003). Sox10 is required for the early development of the prospective neural crest in Xenopus embryos. Dev. Biol. 260, 79-96.
13. Howard, M. J. (2005). Mechanisms and perspectives on differentiation of autonomic neurons. Dev. Biol. 277, 271-286.
14. Kim, J., Lo, L., Dormand, E. and Anderson, D. J. (2003). SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17-31.
15. Knoepfler, P. S., Cheng, P. F. and Eisenman, R. N. (2002). N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712.
16. LaBonne, C. and Bronner-Fraser, M. (2000). Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration. Dev. Biol. 221, 195-205.
17. Lange, C., Huttner, W. B. and Calegari, F. (2009). Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 5, 320-331.
18. Lei, J. and Howard, M. J. (2011). Targeted deletion of Hand2 in enteric neural precursor cells affects its functions in neurogenesis, neurotransmitter specification and gangliogenesis, causing functional aganglionosis. Development 138, 4789-4800.
19. Maris, J. M. (2010). Recent advances in neuroblastoma. N. Engl. J. Med. 362, 2202-2211.
20. Maris, J. M., Hogarty, M. D., Bagatell, R. and Cohn, S. L. (2007). Neuroblastoma. Lancet 369, 2106-2120.
21. Matsuo, T. and Thiele, C. J. (1998). p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16, 3337-3343.
22. Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M. et al. (1999). Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 341, 1165-1173.
23. Mestdagh, P., Fredlund, E., Pattyn, F., Schulte, J. H., Muth, D., Vermeulen, J., Kumps, C., Schlierf, S., De Preter, K., Van Roy, N. et al. (2010). MYCN/c-MYCinduced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 29, 1394-1404.
24. Molenaar, J. J., Ebus, M. E., Koster, J., van Sluis, P., van Noesel, C. J. M., Versteeg, R. and Caron, H. N. (2008). Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res. 68, 2599-2609.
25. Molenaar, J. J., Ebus, M. E., Geerts, D., Koster, J., Lamers, F., Valentijn, L. J., Westerhout, E. M., Versteeg, R. and Caron, H. N. (2009). Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc. Natl. Acad. Sci. USA 106, 12968-12973.
26. Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J. et al. (2012). Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589-593.
27. Nakamura, Y., Ozaki, T., Koseki, H., Nakagawara, A. and Sakiyama, S. (2003). Accumulation of p27KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochem. Biophys. Res. Commun. 307, 206-213.
28. Pang, Z. P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D. R., Yang, T. Q., Citri, A., Sebastiano, V., Marro, S., Sudhof, T. C. et al. (2011). Induction of human neuronal cells by defined transcription factors. Nature 476, 220-223.
29. Parlier, D., Ariza, A., Christulia, F., Genco, F., Vanhomwegen, J., Kricha, S., Souopgui, J. and Bellefroid, E. J. (2008). Xenopus zinc finger transcription factor IA1 (Insm1) expression marks anteroventral noradrenergic neuron progenitors in Xenopus embryos. Dev. Dyn. 237, 2147-2157.
30. Pattyn, A., Morin, X., Cremer, H., Goridis, C. and Brunet, J.-F. (1999). The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399, 366-370.
31. Pugh, T. J., Morozova, O., Attiyeh, E. F., Asgharzadeh, S., Wei, J. S., Auclair, D., Carter, S. L., Cibulskis, K., Hanna, M., Kiezun, A. et al. (2013). The genetic landscape of high-risk neuroblastoma. Nat. Genet. 45, 279-284.
32. Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J. et al. (2013). Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin. Cancer Res. 19, 6173-6182.
33. Rheinbay, E., Suvà, M. L., Gillespie, S. M., Wakimoto, H., Patel, A. P., Shahid, M., Oksuz, O., Rabkin, S. D., Martuza, R. L., Rivera, M. N. et al. (2013). An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep. 3, 1567-1579.
34. Richard-Parpaillon, L., Cosgrove, R. A., Devine, C., Vernon, A. E. and Philpott, A. (2004). G1/S phase cyclin-dependent kinase overexpression perturbs early development and delays tissue-specific differentiation in Xenopus. Development 131, 2577-2586.
35. Rohrer, H. (2011). Transcriptional control of differentiation and neurogenesis in autonomic ganglia. Eur. J. Neurosci. 34, 1563-1573.
36. Sarkar, A. A. and Howard, M. J. (2006). Perspectives on integration of cell extrinsic and cell intrinsic pathways of signaling required for differentiation of noradrenergic sympathetic ganglion neurons. Auton. Neurosci. 126-127, 225-231.
37. Schwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M. and Trent, J. (1983). Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245-248.
38. Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L. and Bunin GR (eds) (1999). Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD.
39. Söderholm, H., Örtoft, E., Johansson, I., Ljungberg, J., Larsson, C., Axelson, H. and Pahlman, S. (1999). Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem. Biophys. Res. Commun. 256, 557-563.
40. Sonnenberg-Riethmacher, E., Miehe, M., Stolt, C. C., Goerich, D. E., Wegner, M. and Riethmacher, D. (2001). Development and degeneration of dorsal root ganglia in the absence of the HMG-domain transcription factor Sox10. Mech. Dev. 109, 253-265.
41. Southard-Smith, E. M., Kos, L. and Pavan, W. J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprungmo use model. Nat. Genet. 18, 60-64.
42. Talikka, M., Stefani, G., Brivanlou, A. H. and Zimmerman, K. (2004). Characterization of Xenopus Phox2a and Phox2b defines expression domains within the embryonic nervous system and early heart field. Gene Expr. Patterns 4, 601-607.
43. Thiele, C. J. and Israel, M. A. (1988). Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Exp. Cell Biol. 56, 321-333.
44. Thiele, C. J., Reynolds, C. P. and Israel, M. A. (1985). Decreased expression of Nmyc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313, 404-406.
45. Unsicker, K., Huber, K., Schütz, G. and Kalcheim, C. (2005). The chromaffin cell and its development. Neurochem. Res. 30, 921-925.
46. Valentijn, L. J., Koster, J., Haneveld, F., Aissa, R. A., van Sluis, P., Broekmans, M. E. C., Molenaar, J. J., van Nes, J. and Versteeg, R. (2012). Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proc. Natl. Acad. Sci. USA 109, 19190-19195.
47. Vernon, A.E., Devine, C. and Philpott, A. (2003). The cdk inhibitor p27Xic1is required for differentiation of primary neurones in Xenopus. Development 130, 85-92.
48. Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C. and Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041.
49. Vosper, J. M. D., Fiore-Heriche, C. S., Horan, I., Wilson, K., Wise, H. and Philpott, A. (2007). Regulation of neurogenin stability by ubiquitin-mediated proteolysis. Biochem. J. 407, 277-284.
50. Vosper, J.M.D., McDowell, G.S., Hindley, C. J., Fiore-Heriche, C.S., Kucerova, R., Horan, I. and Philpott, A. (2009). Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis. J. Biol. Chem. 284, 15458-15468.
51. Wang, C., Liu, Z., Woo, C.-W., Li, Z., Wang, L., Wei, J.S., Marquez, V. E., Bates, S.E., Jin, Q., Khan, J. et al. (2012). EZH2Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res. 72, 315-324.
52. Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. and Bishop, J. M. (1997). Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985-2995.
53. Zhu, S., Lee, J.-S., Guo, F., Shin, J., Perez-Atayde, A. R., Kutok, J. L., Rodig, S. J., Neuberg, D. S., Helman, D., Feng, H. et al. (2012). Activated ALK collaborateswith MYCN in neuroblastoma pathogenesis. Cancer Cell 21, 362-373.